These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32652182)

  • 21. Dissolving microneedles containing aminolevulinic acid improves protoporphyrin IX distribution.
    Requena MB; Permana AD; Vollet-Filho JD; González-Vázquez P; Garcia MR; De Faria CMG; Pratavieira S; Donnelly RF; Bagnato VS
    J Biophotonics; 2021 Jan; 14(1):e202000128. PubMed ID: 32981235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
    Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
    Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic component of protoporphyrin IX production in nude mouse skin upon topical application of aminolevulinic acid depends on the application conditions.
    van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
    Photochem Photobiol; 2002 Feb; 75(2):172-7. PubMed ID: 11885562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
    Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
    Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of ALA-induced PpIX production in porcine skin pretreated with microneedles.
    Rodrigues PG; Campos de Menezes PF; Fujita AK; Escobar A; Barboza de Nardi A; Kurachi C; Bagnato VS
    J Biophotonics; 2015 Sep; 8(9):723-9. PubMed ID: 25319567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles.
    Donnelly RF; McCarron PA; Al-Kassas R; Juzeniene A; Juzenas P; Iani V; Woolfson AD; Moan J
    Biopharm Drug Dispos; 2009 Mar; 30(2):55-70. PubMed ID: 19226650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions.
    McCarron PA; Donnelly RF; Zawislak A; Woolfson AD
    Eur J Pharm Sci; 2006 Feb; 27(2-3):268-79. PubMed ID: 16330192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
    Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
    J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin.
    van den Akker JT; Boot K; Vernon DI; Brown SB; Groenendijk L; van Rhoon GC; Sterenborg HJ
    Photochem Photobiol Sci; 2004 Mar; 3(3):263-7. PubMed ID: 14993942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch.
    Gilmore BF; McCarron PA; Morrow DI; Murphy DJ; Woolfson AD; Donnelly RF
    Eur J Pharm Biopharm; 2006 Jul; 63(3):295-309. PubMed ID: 16682177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.
    Fang YP; Tsai YH; Wu PC; Huang YB
    Int J Pharm; 2008 May; 356(1-2):144-52. PubMed ID: 18325699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model.
    Juzeniene A; Juzenas P; Iani V; Moan J
    Photochem Photobiol; 2002 Sep; 76(3):329-34. PubMed ID: 12403455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model.
    Maisch T; Santarelli F; Schreml S; Babilas P; Szeimies RM
    Exp Dermatol; 2010 Aug; 19(8):e302-5. PubMed ID: 19845760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectroscopic measurements of photoinduced processes in human skin after topical application of the hexyl ester of 5-aminolevulinic acid.
    Zhao L; Nielsen KP; Juzeniene A; Juzenas P; Lani V; Ma LW; Stamnes K; Stamnes JJ; Moan J
    J Environ Pathol Toxicol Oncol; 2006; 25(1-2):307-20. PubMed ID: 16566726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
    Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
    J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical methotrexate pretreatment enhances the therapeutic effect of topical 5-aminolevulinic acid-mediated photodynamic therapy on hamster buccal pouch precancers.
    Yang DF; Lee JW; Chen HM; Hsu YC
    J Formos Med Assoc; 2014 Sep; 113(9):591-9. PubMed ID: 24811932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
    McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
    Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
    Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
    Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.
    Pierre MB; Ricci E; Tedesco AC; Bentley MV
    Pharm Res; 2006 Feb; 23(2):360-6. PubMed ID: 16341572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin.
    Juzeniene A; Juzenas P; Kaalhus O; Iani V; Moan J
    Photochem Photobiol; 2002 Oct; 76(4):452-6. PubMed ID: 12405155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.